FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 348:1797-1799 May 1, 2003 Number 18 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Crespo, M. PubMed Citation

The typical patient with chronic lymphocytic leukemia (CLL) presents to his physician at the time of a routine physical examination as an asymptomatic man who has reached the time in his life when he can enjoy the fruits of his working years. He learns from his physician that he has a somewhat enigmatic type of leukemia, the clinical course and outcome of which vary considerably from patient to patient, and therefore that his outlook is unpredictable. He may be told that some patients live with the disease for decades and die with (and not because of) the disease. He may . . . [Full Text of this Article]

Source Information

From the North Shore–Long Island Jewish Research Institute, Manhasset, N.Y.

This article has been cited by other articles:

• Nowakowski, G. S., Hoyer, J. D., Shanafelt, T. D., Zent, C. S., Call, T. G., Bone, N. D., LaPlant, B., Dewald, G. W., Tschumper, R. C., Jelinek, D. F., Witzig, T. E., Kay, N. E. (2009). Percentage of Smudge Cells on Routine Blood Smear Predicts Survival in Chronic Lymphocytic Leukemia. JCO 27: 1844-1849 [Abstract] [Full Text]  
• Hewamana, S., Lin, T. T., Rowntree, C., Karunanithi, K., Pratt, G., Hills, R., Fegan, C., Brennan, P., Pepper, C. (2009). Rel A Is an Independent Biomarker of Clinical Outcome in Chronic Lymphocytic Leukemia. JCO 27: 763-769 [Abstract] [Full Text]  
• Gribben, J. G. (2008). Role of Allogeneic Hematopoietic Stem-Cell Transplantation in Chronic Lymphocytic Leukemia. JCO 26: 4864-4865 [Full Text]  
• Hauswirth, A. W., Jager, U. (2008). Impact of cytogenetic and molecular prognostic markers on the clinical management of chronic lymphocytic leukemia. haematol 93: 14-19 [Full Text]  
• Steinberg, M., Adjali, O., Swainson, L., Merida, P., Bartolo, V. D., Pelletier, L., Taylor, N., Noraz, N. (2004). T-cell receptor-induced phosphorylation of the {zeta} chain is efficiently promoted by ZAP-70 but not Syk. Blood 104: 760-767 [Abstract] [Full Text]